Drugs / M516102
last change Sep 2010 re-read 3 minutes ago

M516102

Developed for
atopic eczema
Investigated by
Maruho Co., Ltd.

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00980629 Aug 2008 → Sep 2010 atopic eczema Maruho Co., Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as M516102 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00980629 ↗